Issue 35 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

35

September 30, 2005Sep 30, 2005

Free

DOWNLOAD THE PDF

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

Members of Congress say that won’t work.

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

After a “humble” start at NCI, von Eschenbach set unachievable goal.

Recent Issues

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026